Navigation Links
Jovianna DiCarlo Named ConsentSolutions, Inc. President & Chief Executive Officer
Date:3/30/2009

ConsentSolutions, Inc., a provider of electronic informed consent software for clinical research trials has named Jovianna DiCarlo President & Chief Executive Officer. Jovianna DiCarlo brings over 20 years experience driving new pharmaceutical therapeutics and devices through the entire development process from conceptualization, feasibility assessment, through clinical development to commercialization.

Frederick, MD (PRWEB) March 30, 2009 -- ConsentSolutions, Inc., a provider of electronic informed consent software for clinical research trials has named Jovianna DiCarlo President & Chief Executive Officer. Jovianna DiCarlo brings over 20 years experience driving new pharmaceutical therapeutics and devices through the entire development process from conceptualization, feasibility assessment, through clinical development to commercialization.

Ms. DiCarlo most recently served as the Dermatology Clinical Development Manager for NitricBio Therapeutics, Inc., an early stage biotechnology company where she led dermatology product development, and topical infectious disease drug/device development, and clinical trial programs all of which she managed through the identification and implementation of a customized platform of electronic clinical trial management applications.

Additionally, Ms. DiCarlo has utilized her extensive operational technology & regulatory expertise to combine intelligent electronic technology systems integration to develop and map operational and workflow processes to successfully support the launch several full service eCRO's, eIRB's, eSMO's, eResearch consortiums, and dedicated clinical research sites.

"I am passionate about actively contributing clinical research and development initiatives through the development, integration, adoption and implementation of intelligent technology applications to efficiently support clinical operations, and clinical research & development initiatives," said DiCarlo.

"My experience in deploying efficient real-time electronic applications to manage clinical trials leads me to believe that both industry and regulatory authorities will embrace the adoption and use of electronic clinical trial informed consenting practices."

We are pleased that Ms DiCarlo has joined us, says Susan Brink, DrPH, Chairman of the Board. Her track successful track record of applying technology solutions to support clinical trials, along with her business development acumen, EDC/CTMS, IRB, subject recruitment organizations, and CRO industry contacts position her to well to form technology business to business partnerships that will create added value for ConsentSolutions, Inc.

About ConsentSolutions, Inc
Founded in 2005, headquartered in Frederick, Maryland, with offices in Gaithersburg, ConsentSolutions is focused on adding value to the consenting process through the development of interactive, user-friendly educational software to effectively deliver clinical trial information electronically allowing study candidates to make important decisions about clinical trial participation. With decades of combined experience developing educational multimedia applications, ConsentSolutions, Inc. senior management team is dedicated to the goal of shared decision making for trial participation among study candidates, clinical trial coordinators, investigators, and physicians.

For more information contact:

Jovianna DiCarlo, President & CEO
jdicarlo (at) consentsolutions (dot) com
240-575-1918 Ext. 261
267.884.3456
www.consentsolutions.com

# # #

Read the full story at http://www.prweb.com/releases/2009/03/prweb2270884.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Kendle Senior Scientist Edward Sellers, MD, PhD, Named One of Nine Notable People in R&D
2. US Oncology Named to FORTUNE Magazines Most Admired Companies List for Third Time
3. Former President of Sports Cardiology Consultants, LLC Christine Lawless, MD, MBA, ABCL, FACC, FACSM, Named Medical Director of CME Enterprise
4. Zymetis Inc. Named Top 50 Cleantech/Greentech Company
5. BioNanomatrixs Revolutionary Whole Genome Analysis Platform Named to MIT Technology Reviews Annual 10 Emerging Technologies List
6. Investor Group Files Complaint With Irish Office of the Director of Corporate Enforcement Against Named Directors of Trinity Biotech
7. Neogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry
8. Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research
9. Kendle Named a Best Place to Work in Greater Cincinnati
10. Sinovac Named to Deloitte Technology Fast 50 China
11. AMERIGROUP Corporation Named One of Best Places to Work in Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. This ... products engineered to radically streamline culture processes, minimize processing time, significantly decrease ...
(Date:12/8/2016)...  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a clinical ... to commercialize innovative therapeutics for patients with cancer, ... approved for trading on the OTCQX U.S. market. ... effective today, under the ticker symbol "HPPI." ... must meet high financial standards, follow best practice ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. presented ... expansion clinical trial for its lead drug candidate, AC0010, at the World Conference ... was to determine the safety, antitumor activity, and recommended phase II dosage of ...
(Date:12/7/2016)... 2016 /PRNewswire/ - Zenith Capital Corp. ("Zenith" or the "Company") announces ... at the Company,s Annual and Special Meeting. ... place on Thursday, December 15, 2016 at Mount ... EC1040), 4825 Mount Royal Gate SW, Calgary, Alberta ... meeting and management information circular, containing the matters to be ...
Breaking Biology Technology:
(Date:12/2/2016)... , December 1, 2016 ... type (Fingerprint, Voice), Future Technology (Iris Recognition System), ... Region - Global Forecast to 2021", published by ... 442.7 Million in 2016, and is projected to ... a CAGR of 14.06%.      (Logo: ...
(Date:11/30/2016)... , Nov. 30, 2016  higi SH llc ... partnership initiative targeting national brands, industry thought-leaders and ... their respective audiences for taking steps to live ... inception in 2012, higi has built the largest ... over 38 million people who have conducted over ...
(Date:11/29/2016)... France , November 29, 2016 Nearly one ... Continue Reading ... ... is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: ...
Breaking Biology News(10 mins):